Lice Treatment Market Poised for Significant Growth, Projected to Reach USD 1,684.72 Million Growing at 5.9% CAGR by 2032

𝐆𝐥𝐨𝐛𝐚𝐥 𝐥𝐢𝐜𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐚𝐧𝐝 𝐬𝐡𝐚𝐫𝐞 𝐢𝐬 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟏,𝟎𝟏𝟖.𝟕𝟕 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐚𝐧 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 𝟏,𝟔𝟖𝟒.𝟕𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐 , 𝐚𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐬𝐭𝐮𝐝𝐲 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡. 𝐁𝐞𝐬𝐢𝐝𝐞𝐬, 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐭𝐞𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐬 𝐚 𝐫𝐨𝐛𝐮𝐬𝐭 𝟓.𝟗% 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐢𝐦𝐞𝐟𝐫𝐚𝐦𝐞, 𝟐𝟎𝟐𝟒 - 𝟐𝟎𝟑𝟐

Lice are tiny, wingless parasites that attach to human hair and feed on human blood. The common types of lice include head lice, body lice and pubic lice, with head lice being the most prevalent kind of lice. Lice eggs, which are laid right onto the shaft of the hair, take about a week to hatch. Lice typically feed on human blood multiple times every day. Treatment for lice is recommended for individuals diagnosed with an active infestation. Head lice require a human host to survive. As such, cutting hair is a viable course of action for some people.

𝐂𝐥𝐢𝐜𝐤 𝐭𝐨 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐧𝐝 𝐃𝐫𝐢𝐯𝐞 𝐈𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬:
https://www.polarismarketresearch.com/industry-analysis/lice-treatment-market/request-for-sample

The market for lice treatment is fragmented. It is projected to witness competition owing to the presence of several key players. The top industry participants, who are competing on various factors like enhancing product efficacy and strong marketing campaigns, include:

• Arbor Pharmaceuticals LLC (US)
• Bayer AG (Germany)
• Insight Pharmaceuticals (US)
• Omega Pharma NV (Belgium)
• Parasol Laboratories (US)
• Pfizer Inc. (US)
• Prestige Brands Holding Inc. (US)
• Sanofi SA (France)
• Sumitomo Chemical Co. Ltd. (Japan)
• TAA Industries (Australia)
• TecLabs Inc. (US)
• Tyratech Inc. (US)

Besides, over-the-counter (OTC) products and prescription treatments may be used to live lice and their eggs. Drugs commonly prescribed by doctors to deal with lice include ivermectin, malathion, and Spinosad. If other treatment options don't seem to work, the healthcare professional might recommend Ivermectin tablets to be taken orally.

𝐆𝐞𝐭 𝐀𝐡𝐞𝐚𝐝 𝐰𝐢𝐭𝐡 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/buy/3751/2

𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬

Over the past few years, there has been a drastic change in people's lifestyles like hygiene practices and changes in living standards. This, in turn, is contributing to the increased prevalence of lice and propelling the demand for effective treatment options.

Governments worldwide are mandating the implementation of lice control measures in several settings, such as schools, hospitals, and daycare centers. The growing number of product approvals by regulatory authorities for lice treatment infestations is anticipated to boost the global lice treatment market growth.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

𝐋𝐢𝐜𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭, 𝐓𝐲𝐩𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐌𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟐𝟑 - 𝟐𝟎𝟑𝟐)
• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis

𝐋𝐢𝐜𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭, 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐌𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟐𝟑 - 𝟐𝟎𝟑𝟐)
• OTC Products
• Prescription Medications
• Others

𝐋𝐢𝐜𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭, 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐌𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟐𝟑 - 𝟐𝟎𝟑𝟐)
• Hospitals and Clinics
• Retail Pharmacies
• Online Platform
• Others

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:
𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐋𝐢𝐜𝐞 𝐈𝐧𝐟𝐞𝐬𝐭𝐚𝐭𝐢𝐨𝐧𝐬: Lice infestations are common worldwide, particularly among school-aged children, leading to a consistent demand for effective lice treatment products and services.

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧: Growing awareness about lice infestations, their transmission, and the importance of prompt treatment among parents, educators, and healthcare professionals contribute to the growth of the lice treatment market.

𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬: Advances in lice treatment technologies, including the development of novel pediculicides, mechanical removal devices, and electronic lice combs, enhance treatment efficacy and convenience for consumers.

𝐂𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐋𝐢𝐜𝐞 𝐑𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 𝐏𝐚𝐭𝐭𝐞𝐫𝐧𝐬: The emergence of lice strains resistant to traditional pediculicides, such as pyrethroids, drives the demand for alternative treatment options and fuels innovation in the lice treatment market.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬: https://www.polarismarketresearch.com/industry-analysis/lice-treatment-market

𝐋𝐢𝐜𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• Pediculosis capitis segment accounted for notable share, on account of growing incidences of head lice and awareness about the importance of early detection

• OTC products segment held the majority share, that is attributed to its benefits including convenience and cost-effectiveness

• Hospital pharmacies segment will grow at fastest pace, due to rising number of patients undergoing treatments in hospitals and easy availability of prescription medications

• North America dominated the global market, owing to region's well-established healthcare infrastructure and increased disposable income of consumers

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐈𝐧𝐭𝐫𝐚𝐯𝐞𝐧𝐨𝐮𝐬 𝐈𝐦𝐦𝐮𝐧𝐨𝐠𝐥𝐨𝐛𝐮𝐥𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market

𝐀𝐮𝐝𝐢𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/global-audiology-devices-market

𝐁𝐨𝐭𝐮𝐥𝐢𝐧𝐮𝐦 𝐓𝐨𝐱𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/global-botulinum-toxin-market

𝐂𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.